Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Moderna, Inc. - Common Stock
(NQ:
MRNA
)
198.85
-1.25 (-0.62%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Azenta, Myriad Genetics, Moderna, Repligen, and PacBio Shares Plummet, What You Need To Know
October 16, 2026
What Happened? A number of stocks fell in the afternoon session after capital-intensive growth equities experienced sharp sell-offs as elevated bond yields r...
Via
StockStory
Topics
Bonds
Economy
S&P 500 Top Movers: Today's Gainers and Losers
↗
October 16, 2026
Via
Chartmill
Topics
Stocks
Most-Active S&P 500 Stocks in Oct. 16, 2026 US Session
↗
October 16, 2026
Via
Chartmill
Topics
Stocks
S&P 500 Top Movers Today: HONA Tops Gainers, TWLO Tops Decliners
↗
October 16, 2026
Via
Chartmill
Topics
Stocks
S&P 500 Gap Downs on October 16: MRNA, TWLO and COHR Lead Declines
↗
October 16, 2026
Via
Chartmill
Topics
Stocks
Meet the New Nasdaq-100 Stock That’s Crushing Nvidia, Micron, and Sandisk. Is It Too Late to Buy?
↗
October 16, 2026
This stock has soared more than 600% this year.
Via
The Motley Fool
Topics
Artificial Intelligence
Discover which S&P500 stocks are making waves on Thursday.
↗
October 15, 2026
Via
Chartmill
Top S&P500 movers in Wednesday's session
↗
October 14, 2026
Via
Chartmill
AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test
October 14, 2026
From
Biotech Insider
Via
GlobeNewswire
Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
↗
October 13, 2026
Vertex raised its full-year outlook in Q2 with a growing pipeline across multiple disease areas. Moderna’s mRNA flu vaccine just cleared a key FDA hurdle with an expanding oncology pipeline behind it.
Via
The Motley Fool
Tuesday's pre-market session: top gainers and losers in the S&P500 index
↗
October 13, 2026
Via
Chartmill
Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026
October 13, 2026
From
Moderna, Inc.
Via
ACCESS Newswire
Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick?
↗
October 13, 2026
Is bigger always better? Not necessarily.
Via
The Motley Fool
These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys?
↗
October 12, 2026
Forget the "Magnificent Seven" in favor of the "Tremendous Three"?
Via
The Motley Fool
Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell?
↗
October 10, 2026
After a few years of stagnation, this stock is soaring.
Via
The Motley Fool
Why Moderna Stock Surged Today
↗
October 09, 2026
The biotech could play a significant role in a national effort to combat cancer.
Via
The Motley Fool
Topics
Artificial Intelligence
This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street
↗
October 09, 2026
Have Moderna’s shares risen too much, too fast?
Via
The Motley Fool
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session.
↗
October 09, 2026
Via
Chartmill
Discover which S&P500 stocks are making waves on Friday.
↗
October 09, 2026
Via
Chartmill
Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?
↗
October 07, 2026
Axsome is posting 65% revenue growth but burning cash, while Moderna's vaccine market is cooling yet its oncology pipeline carries transformative potential.
Via
The Motley Fool
Exploring the top movers within the S&P500 index during today's session.
↗
October 07, 2026
Via
Chartmill
Is Now the Time to Cash Out of the S&P 500's Top 3 Stocks of 2026?
↗
October 06, 2026
These stocks have all soared more than 350% this year.
Via
The Motley Fool
Topics
Artificial Intelligence
Stocks
Uncover the latest developments among S&P500 stocks in today's session.
↗
October 06, 2026
Via
Chartmill
Which S&P500 stocks are moving on Tuesday?
↗
October 06, 2026
Via
Chartmill
Tuesday's session: gap up and gap down stock in the S&P500 index
↗
October 06, 2026
Via
Chartmill
Uncover the latest developments among S&P500 stocks in today's session.
↗
October 05, 2026
Via
Chartmill
A Soft Jobs Report Takes the Heat Off Rates, and Nvidia Closes In on $6 Trillion
↗
October 05, 2026
Via
Chartmill
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds
October 05, 2026
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Lu...
Via
StockStory
Topics
Economy
Stocks making big moves yesterday: United Therapeutics, Moderna, Jabil, Concentrix, and FactSet
October 01, 2026
Check out the companies making headlines yesterday: United Therapeutics (NASDAQ:UTHR): Biotechnology company United Therapeutics (NASDAQ:UTHR) rose by 13.6% ...
Via
StockStory
Topics
Intellectual Property
If I Could Tell Every New Investor 1 Thing About Building Wealth in the Stock Market, It's This
↗
October 01, 2026
New investors might be eager to jump in during a bull market.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.